OCRX seems like data for the STOP-HE Phase 2b study of OCR-002 in patients with hepatic encephalopathy is due very shortly?
Estimated Enrollment: 230 Study Start Date: November 2013 Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.